Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation
Journal of Medicinal Chemistry · 23.05.2024 · 67 (10) · 8225-8246
DOI: 10.1021/acs.jmedchem.4c00322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.05.2024. Verfasst von Sunny Goon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, WB, India. Hauptthemen laut MEDLINE: Ion Channels, T-Lymphocytes. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, University Grants Commission.
Abstract (Originalsprache)
Piezo1, a mechano-activated ion channel, has wide-ranging physiological and therapeutic implications, with the ongoing development of specific agonists unveiling cellular responses to mechanical stimuli. In our study, we systematically analyzed the chemical subunits in Piezo1 protein agonist Yoda1 to comprehend the structure-activity relationship and push forward next-generation agonist development. Preliminary screening assays for Piezo1 agonism were performed using the Piezo1-mCherry-transfected HEK293A cell line, keeping Yoda1 as a positive control. We introduce a novel Piezo1 agonist Yaddle1 (34, 0.40 μM), featuring a trifluoromethyl group, with further exploration through in vitro studies and density functional theory calculations, emphasizing its tetrel interactions, to act as an ambidextrous wedge between the domains of Piezo1. In contrast to the poor solubility of the established agonist Yoda1, our results showed that the kinetic solubility of Yaddle1 (26.72 ± 1.8 μM at pH 7.4) is 10-fold better than that of Yoda1 (1.22 ± 0.11 μM at pH 7.4). Yaddle1 (34) induces Ca2+ influx in human CD4+ T cell, suggesting its potential as a vaccine adjuvant for enhanced T cell activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, WB, India.
- IICB-Translational Research Unit of Excellence, Department of Cancer Biology and Inflammatory Disorders, CSIR-Indian Institute of Chemical Biology, CN6, Sector V, Salt Lake, Kolkata 700091, WB, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
ORCID-Profile: Himadri Sekhar Sarkar, Arindam Talukdar
Förderung
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
- University Grants Commission
- National Institute of Pharmaceutical Education and Research, Kolkata
- Indian Institute of Science Education and Research Pune
Zitieren
APA
Goon, S., Shiu Chen Liu, C., Ghosh Dastidar, U., Paul, B., Mukherjee, S., Sarkar, H. S., Desai, M., Jana, R., Pal, S., Sreedevi, N. V., Ganguly, D., & Talukdar, A. (2024). Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation. Journal of Medicinal Chemistry, 67(10), 8225-8246. https://doi.org/10.1021/acs.jmedchem.4c00322
Vancouver
Goon S, Shiu Chen Liu C, Ghosh Dastidar U, Paul B, Mukherjee S, Sarkar HS, et al. Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation. Journal of Medicinal Chemistry. 2024;67(10):8225-8246. doi:10.1021/acs.jmedchem.4c00322
BibTeX
@article{Goon2024,
author = {Goon, Sunny and Shiu Chen Liu, Chinky and Ghosh Dastidar, Uddipta and Paul, Barnali and Mukherjee, Suravi and Sarkar, Himadri Sekhar and Desai, Milie and Jana, Rituparna and Pal, Sourav and Sreedevi, Namala Venkata and Ganguly, Dipyaman and Talukdar, Arindam},
title = {Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {10},
pages = {8225--8246},
doi = {10.1021/acs.jmedchem.4c00322}
}
EUVIMED